Literature DB >> 22608842

Prevalence of hepatitis B virus infection among tuberculosis patients with or without HIV in Goiânia City, Brazil.

R S Aires1, M A D Matos, C L R Lopes, S A Teles, A G Kozlowski, A M C Silva, J A A Filho, B V Lago, F C A Mello, R M B Martins.   

Abstract

BACKGROUND: Hepatitis B virus (HBV) and tuberculosis (TB) represent major public health problems. There is currently little data on HBV infection among TB patients with and without human immunodeficiency virus (HIV).
OBJECTIVES: To assess HBV prevalence among TB patients with and without HIV. STUDY
DESIGN: From April 2008 to March 2010, a cross-sectional study was conduct among TB patients attended at a reference hospital in Goiânia City, Brazil. The participants were tested for serological markers of HBV infection and HIV antibodies. HBV DNA was detected in HBsAg-positive samples, and also in HBsAg-negative/anti-HBc-positive samples to look for HBV occult infection.
RESULTS: Of 425 patients, 402 (94.6%) agreed to participate in the study. The overall prevalence of HBV (HBsAg and/or anti-HBc positive) and HIV infections were 25.6% (103/402) and 27.6% (111/402), respectively. A higher HBV infection rate was found among HIV-infected patients (36.9%; 41/111) compared to patients infected with TB only (20.0%; 57/285). A multivariate analysis of risk factors showed that age ≥ 50 years (p=0.03), non-injecting (p<0.01) and injecting (p<0.01) drugs use were associated with HBV infection. Among the HBsAg-positive samples (n=13), HBV DNA was detected in 10 (76.9%) samples. Of the 90 anti-HBc-positive samples, 13 were HBV DNA positive (with very low levels) resulting in an occult HBV infection rate of 14.4%. PCR-RFLP was successfully performed in 20 HBV DNA-positive samples: 15 were genotype A and 5 were genotype D.
CONCLUSIONS: HBV infection was common, particularly among this with HIV infection.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22608842     DOI: 10.1016/j.jcv.2012.04.006

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  8 in total

1.  Seroprevalence and Associated Factors of Hepatitis B and C Virus Among Pulmonary Tuberculosis Patients Attending Health Facilities in Gondar Town, Northwest Ethiopia.

Authors:  Birhanu Getie; Getnet Ayalew; Anteneh Amsalu; Getachew Ferede; Gizachew Yismaw; Belay Tessema
Journal:  Infect Drug Resist       Date:  2021-09-03       Impact factor: 4.003

2.  Viral hepatitis prevalence in patients with active and latent tuberculosis.

Authors:  Hesam Ahmadi Nooredinvand; David W Connell; Mahmoud Asgheddi; Mohammed Abdullah; Marie O'Donoghue; Louise Campbell; Melissa I Wickremasinghe; Ajit Lalvani; Onn Min Kon; Shahid A Khan
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

3.  Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000-2010.

Authors:  G Bushnell; N L Stennis; A M Drobnik; D C Proops; S D Ahuja; K Bornschlegel; J Fuld
Journal:  Epidemiol Infect       Date:  2014-11-12       Impact factor: 4.434

4.  Impacts of hepatitis B and hepatitis C co-infection with tuberculosis, a prospective cohort study.

Authors:  Berhanu Elfu Feleke; Teferi Elfu Feleke; Wondimu Gebrekiros Adane; Abel Girma
Journal:  Virol J       Date:  2020-07-23       Impact factor: 4.099

Review 5.  Examining the Complex Relationship Between Tuberculosis and Other Infectious Diseases in Children.

Authors:  Elizabeth Whittaker; Elisa López-Varela; Claire Broderick; James A Seddon
Journal:  Front Pediatr       Date:  2019-06-25       Impact factor: 3.418

Review 6.  Molecular epidemiology of Mycobacterium tuberculosis in Brazil before the whole genome sequencing era: a literature review.

Authors:  Emilyn Costa Conceição; Richard Steiner Salvato; Karen Machado Gomes; Arthur Emil Dos Santos Guimarães; Marília Lima da Conceição; Ricardo José de Paula Souza E Guimarães; Abhinav Sharma; Ismari Perini Furlaneto; Regina Bones Barcellos; Valdes Roberto Bollela; Lívia Maria Pala Anselmo; Maria Carolina Sisco; Cristina Viana Niero; Lucilaine Ferrazoli; Guislaine Refrégier; Maria Cristina da Silva Lourenço; Harrison Magdinier Gomes; Artemir Coelho de Brito; Marcos Catanho; Rafael Silva Duarte; Philip Noel Suffys; Karla Valéria Batista Lima
Journal:  Mem Inst Oswaldo Cruz       Date:  2021-03-15       Impact factor: 2.743

Review 7.  Tuberculosis challenges: Resistance, co-infection, diagnosis, and treatment.

Authors:  Mohsen Heidary; Maryam Shirani; Melika Moradi; Mehdi Goudarzi; Ramin Pouriran; Tayebe Rezaeian; Saeed Khoshnood
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2022-04-14

8.  [Impact of HIV status on the overall prevalence of chronic hepatitis B infection in Parakou, Benin].

Authors:  Salimanou Ariyoh Amidou; Comlan Albert Dovonou; Corine Houehanou; Arsène Amadohoué Kpangon; Rhonel Ahanhanzo-Glele; Julie Hounnouga Kpangon; Khadidjatou Saké Alassan; Attinsounon Cossi Angelo; Blaise Tchaou; Kabibou Salifou; Thierry Adoukonou; Djimon Marcel Zannou; Dismand Stephan Houinato
Journal:  Pan Afr Med J       Date:  2018-06-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.